HORIZON-MISS-2024-CANCER-01-02

Support dialogue towards the development of national cancer data nodes -

⚫ indicates current topic
Node background color indicates the call topic status
Double click on a topic to center information around it.
Node size is proportional to distance from the current topic

About the connections

The graph above was generated based on the following links

  • DIGITAL-2026-AI-09-DS-HEALTH-TOOL
    Health: Data ingestion capacities and data services for the European Genomic Data Infrastructure in the European Health Data Space: data tools

    MOTIVATION Relevant projects to consider in proposals

  • DIGITAL-2026-AI-09-DS-HEALTH-STORAGE
    Health: Data ingestion capacities and data services for the European Genomic Data Infrastructure in the European Health Data Space: data storage and processing capacity

    MOTIVATION Relevant projects to consider in proposals

Call text (as on F&T portal)

View on F&T portal
Expected Outcome:

Data is an essential resource to improve our understanding of cancer, advance prevention and early detection strategies, facilitate the delivery of personalised care, and better address the quality of life of cancer patients and survivors.

The Cancer Mission supports the creation of the European Initiative to Understand Cancer (UNCAN.eu, a federated European cancer research data infrastructure) and the European Cancer Patient Digital Centre (ECPDC, a European network of national digital infrastructures for cancer patients)[1].

The proposal under this topic is expected to contribute to all of the following outcomes:

  • Advance the process of establishing National cancer data nodes[2], by the scaling-up or improvement of existing national health data infrastructures and by fostering their links to the European Health Data Space infrastructures for primary and secondary data uses.
  • Potential barriers that may prevent the effective implementation of UNCAN.eu and ECPDC digital platforms are identified and a way forward to address them proposed.
Scope:

The proposal should address all of the following:

  • Foster the development of national cancer data nodes through policy dialogues at national level with relevant actors in the research and innovation community, digital health and public health policy.
  • Identify and build synergies between European infrastructures related to health data access and health data sharing for primary and secondary data uses (e.g. MyData@eu, HealthData@eu, ELIXIR, BBMRI, and others), and other initiatives relevant for the UNCAN.eu and ECPDC platforms.
  • Identify challenges and barriers to the effective future implementation of the UNCAN.eu and the ECPDC platforms at national and European levels and propose operational solutions to overcome them.
  • Identify population subgroups with poor digital skills and geographical areas with limited digital resources that might prevent the use of those platforms and propose solutions to reduce the digital divide.

The involvement of cancer research centres, digital infrastructures, public health bodies, policy makers and cancer patient organisations will ensure that the UNCAN.eu and ECPDC platforms will deliver effective outcomes for researchers, clinicians, healthcare providers, cancer patients, survivors, and caregivers.

Due consideration should be given to EU-funded initiatives, infrastructures and projects such as: EOSC4cancer[3] canSERV[4], the European Cancer Information System[5], and the successful proposals resulting from the topics; HORIZON-MISS-2024-CANCER-01-01, HORIZON-MISS-2024-CANCER-01-06.

This topic requires the effective contribution of Social Sciences and Humanities (SSH) disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, to produce meaningful and significant effects enhancing the societal impact of the related research activities.

The Commission will facilitate coordination. Therefore, successful proposals should include a budget for networking, attendance at meetings, and potential joint activities without the prerequisite to give details of these at this stage. Examples are: organising joint workshops, establishing best practices, joint communication or citizen engagement activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate. Successful proposals will be asked to join the 'Understanding' and ‘Quality of Life’ clusters for the Mission on Cancer established in 2022 and 2023. The details of joint activities will be defined during the grant agreement preparation phase and during the life of the project.

[1] https://research-and-innovation.ec.europa.eu/system/files/2021-09/cancer_implementation_plan_for_publication_final_v2.pdf

[2] Cancer data nodes are built on European and national computing infrastructures that link different cancer data holders across European countries. Cancer data nodes can encompass medical images, digital pathology, clinical data, genomics and other omics data, cancer models, environmental and other relevant data for cancer research.

[3] https://eosc4cancer.eu/

[4] https://www.canserv.eu/

[5] https://ecis.jrc.ec.europa.eu/info/cancer_registries.html

News flashes

2026-01-24

HORIZON-MISS-2024-CANCER-01-02

Published: 18 April 2024

Deadline: 18 September 2024

Available budget: EUR 3,000,000.00

We recently informed the applicants about the evaluation results for their proposals.

Number of proposals submitted (including proposals transferred from or to other calls): 4

Number of inadmissible proposals: 0

Number of ineligible proposals: 0

Number of above-threshold proposals: 2

Total budget requested for above-threshold proposals: € 6,055,336.25

Number of proposals retained for funding: 1

Number of proposals in the reserve list: 1

Funding threshold: 13.0

Number of proposals with scores lower or equal to 15 and higher or equal to 14: 0

Number of proposals with scores lower than 14 and higher or equal to 13: 1

Number of proposals with scores lower than 13 and higher or equal to 12: 1

Summary of observer’s report:

The HORIZON-HLTH-2024-DISEASE-09 (EUR 100 million) and HORIZON-MISS-2024-CANCER-01 (EUR 119 million) evaluations took place between October and November 2024. These strategically important Horizon Europe calls were evaluated using the European Commission’s evaluation IT system SEP. A total of 86 eligible applications were evaluated by experts from Europe and around the world.

They had expertise in public health, life sciences, private sector, artificial intelligence (AI), gender, social sciences & humanities (SSH), clinical trials, anti-microbial resistance (AMR), child, adolescent and young adult (CAYA) cancer research, innovation, health technology assessment (HTA), health economy, healthcare, etc. This resulted in the ranking of proposals to be funded using EU standard ranking evaluation and topic-specific ranking mechanisms.

The call evaluation process was fair, transparent, and robust. Every step of the evaluation followed the rules, guidelines and decision-making processes required for the proper evaluation of EU calls. Across all panels, experts highlighted the opportunity to leverage their know-how to give more detailed feedback to the applicants.

An underlying value of the expert group was the continuous engagement throughout the evaluation process to do the right thing for health in Europe and for citizens to ensure that the best proposals were recommended for funding. A systemic examination of documentation, communication processes and report quality combined with observing meetings and individual and group feedback demonstrated that the current process was robust. There is potential to adapt and plan the evaluation process considering the increasing quantity and quality of applications the EU receives. This may include increasing the quality of the briefing material included in the documentation, providing more detailed guidance on horizontal evaluation aspects, and reinforcing the role of recorders and how they should interact with the moderators and the evaluators.

For questions, please contact the Research Enquiry Service.

2026-01-24

Call HORIZON-MISS-2024-CANCER-01 closed on 18 September 2024.

90 proposals have been submitted.

The breakdown per topic is:

  • HORIZON-MISS-2024-CANCER-01-01: 3 proposals
  • HORIZON-MISS-2024-CANCER-01-02: 4 proposals
  • HORIZON-MISS-2024-CANCER-01-03: 33 proposals
  • HORIZON-MISS-2024-CANCER-01-04: 2 proposals
  • HORIZON-MISS-2024-CANCER-01-05: 42 proposals
  • HORIZON-MISS-2024-CANCER-01-06: 6 proposals

Evaluation results are expected to be communicated in late December 2024.

2026-01-24

HORIZON-MISS-2024-CANCER-01-02

Published: 18 April 2024

Deadline: 18 September 2024

Available budget: EUR 3,000,000.00

We recently informed the applicants about the evaluation results for their proposals.

Number of proposals submitted (including proposals transferred from or to other calls): 4

Number of inadmissible proposals: 0

Number of ineligible proposals: 0

Number of above-threshold proposals: 2

Total budget requested for above-threshold proposals: € 6,055,336.25

Number of proposals retained for funding: 1

Number of proposals in the reserve list: 1

Funding threshold: 13.0

Number of proposals with scores lower or equal to 15 and higher or equal to 14: 0

Number of proposals with scores lower than 14 and higher or equal to 13: 1

Number of proposals with scores lower than 13 and higher or equal to 12: 1

Summary of observer’s report:

The HORIZON-HLTH-2024-DISEASE-09 (EUR 100 million) and HORIZON-MISS-2024-CANCER-01 (EUR 119 million) evaluations took place between October and November 2024. These strategically important Horizon Europe calls were evaluated using the European Commission’s evaluation IT system SEP. A total of 86 eligible applications were evaluated by experts from Europe and around the world.

They had expertise in public health, life sciences, private sector, artificial intelligence (AI), gender, social sciences & humanities (SSH), clinical trials, anti-microbial resistance (AMR), child, adolescent and young adult (CAYA) cancer research, innovation, health technology assessment (HTA), health economy, healthcare, etc. This resulted in the ranking of proposals to be funded using EU standard ranking evaluation and topic-specific ranking mechanisms.

The call evaluation process was fair, transparent, and robust. Every step of the evaluation followed the rules, guidelines and decision-making processes required for the proper evaluation of EU calls. Across all panels, experts highlighted the opportunity to leverage their know-how to give more detailed feedback to the applicants.

An underlying value of the expert group was the continuous engagement throughout the evaluation process to do the right thing for health in Europe and for citizens to ensure that the best proposals were recommended for funding. A systemic examination of documentation, communication processes and report quality combined with observing meetings and individual and group feedback demonstrated that the current process was robust. There is potential to adapt and plan the evaluation process considering the increasing quantity and quality of applications the EU receives. This may include increasing the quality of the briefing material included in the documentation, providing more detailed guidance on horizontal evaluation aspects, and reinforcing the role of recorders and how they should interact with the moderators and the evaluators.

For questions, please contact the Research Enquiry Service.

2026-01-24

Call HORIZON-MISS-2024-CANCER-01 closed on 18 September 2024.

90 proposals have been submitted.

The breakdown per topic is:

  • HORIZON-MISS-2024-CANCER-01-01: 3 proposals
  • HORIZON-MISS-2024-CANCER-01-02: 4 proposals
  • HORIZON-MISS-2024-CANCER-01-03: 33 proposals
  • HORIZON-MISS-2024-CANCER-01-04: 2 proposals
  • HORIZON-MISS-2024-CANCER-01-05: 42 proposals
  • HORIZON-MISS-2024-CANCER-01-06: 6 proposals

Evaluation results are expected to be communicated in late December 2024.

2024-04-18
The submission session is now available for: HORIZON-MISS-2024-CANCER-01-01(HORIZON-RIA), HORIZON-MISS-2024-CANCER-01-04(HORIZON-CSA), HORIZON-MISS-2024-CANCER-01-02(HORIZON-CSA), HORIZON-MISS-2024-CANCER-01-03(HORIZON-IA), HORIZON-MISS-2024-CANCER-01-05(HORIZON-RIA), HORIZON-MISS-2024-CANCER-01-06(HORIZON-IA)
2024-04-18
The submission session is now available for: HORIZON-MISS-2024-CANCER-01-01(HORIZON-RIA), HORIZON-MISS-2024-CANCER-01-04(HORIZON-CSA), HORIZON-MISS-2024-CANCER-01-02(HORIZON-CSA), HORIZON-MISS-2024-CANCER-01-03(HORIZON-IA), HORIZON-MISS-2024-CANCER-01-05(HORIZON-RIA), HORIZON-MISS-2024-CANCER-01-06(HORIZON-IA)
call topic details
Call status: Closed
Publication date: 2024-04-18 (1 year ago)
Opening date: 2024-04-18 (1 year ago)
Closing date: 2024-09-18 (1 year ago)
Procedure: single-stage

Budget: 3,000,000
Expected grants: 1
Contribution: 3,000,000 - 3,000,000
News flashes

This call topic has been appended 6 times by the EC with news.

  • 2026-01-24
    horizon-miss-2024-cancer-01-02published:...
  • 2026-01-24
    call horizon-miss-2024-cancer-01 closed...
  • 2026-01-24
    horizon-miss-2024-cancer-01-02published:...
  • 2026-01-24
    call horizon-miss-2024-cancer-01 closed...
  • 2024-04-18
    the submission session is now available...
  • 2024-04-18
    the submission session is now available...
Call

HORIZON-MISS-2024-CANCER-01

Call topics are often grouped together in a call. Sometimes this is for a thematic reason, but often it is also for practical reasons.

There are 5 other topics in this call:

Source information

Showing the latest information. Found 6 versions of this call topic in the F&T portal.

Information from

  • 2025-07-02_03-33-04
  • 2025-02-06_03-30-17
  • 2024-11-23_03-30-16
  • 2024-11-04_17-25-10
  • 2024-09-30_21-20-58
  • 2024-07-11_18-29-25

Check the differences between the versions.

Annotations (will be publicly visible when approved)

You must be logged in to add annotations
No annotations yet

Events

This is just a very first implementation, better visualisation coming

Events are added by the ideal-ist NCP community and are hand-picked. If you would like to suggest an event, please contact idealist@ffg.at.

Call topic timeline

What phase of the topic timeline are we in? This timeline contains some suggestions on what are realistic actions you should or could take at this moment. The timeline is based on the information provided by the call topic.
  1. Work programme available

    - 1 year ago

    The call topics are published first in the Work Programme, which is available a while before the call opens. By following up the Work Programme publications, you can get a headstart.

  2. Publication date

    - 1 year ago

    The call was published on the Funding & Tenders Portal.

  3. Opening date

    - 1 year ago

    The call opened for submissions.

  4. Closing date

    - 1 year ago

    Deadline for submitting a project.

  5. Time to inform applicants Estimate

    - 11 months ago

    The maximum time to inform applicants (TTI) of the outcome of the evaluation is five months from the call closure date.

  6. Sign grant agreement Estimate

    - 8 months ago

    The maximum time to sign grant agreements (TTG) is three months from the date of informing applicants.

  7. Today

Funded Projects

Loading...

Project information comes from CORDIS (for Horizon 2020 and Horizon Europe) and will be sourced from F&T Portal (for Digital Europe projects)

Bubbles

This call topic is part of: